Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

kConFab, Lim, Elgene, Vaillant, François, Wu, Di, Forrest, Natasha C, Pal, Bhupinder, Hart, Adam H, Asselin-Labat, Marie-Liesse +13 more·2009·Nature Medicine
DOI 10.1038/nm.2000

Cited by (1,001)

Items 801–900 of 1,001

  1. Deciphering breast cancer dynamics: insights from single-cell and spatial profiling in the multi-omics era
    Xin Xiong, Xin Wang, Cuicui Liu, Zhi-Ming Shao, Ke‐Da Yu · 2024 · Biomarker Research
  2. Defining breast epithelial cell types in the single-cell era
    G. Kenneth Gray, Eric Gustav Carlson, Tatyana Lev, Bailey Marshall, Austin D. Reed, Alex P. Sanchez Covarrubias, Alecia‐Jane Twigger, Aleix Puig-Barbe, Aatish Thennavan, Ayodele J. Omotoso et al. · 2025 · Developmental Cell
  3. NF-κB at the Crossroads of Normal Mammary Gland Biology and the Pathogenesis and Prevention of BRCA1-Mutated Breast Cancer
    A. C. SAU, Miguel A. Cabrita, M.A. Christine Pratt · 2017 · Cancer Prevention Research
  4. Oncogenic Mutations in Tumorigenesis and Targeted Therapy in Breast Cancer
    Brijesh Kumar, Vaibhav Chand, Anupama Ram, Darksha Usmani, Naoshad Muhammad · 2020 · Current Molecular Biology Reports
  5. Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer
    J. Saunus, X. D. de Luca, Korinne S. Northwood, A. Raghavendra, A. Hasson, A. McCart Reed, M. Lim, Samir Lal, A. Vargas, J. Kutasovic et al. · 2022 · npj Breast Cancer
  6. BRCA1/2 Haploinsufficiency: Exploring the Impact of Losing one Allele
    Anna Minello, Aura Carreira · 2023 · Journal of Molecular Biology
  7. Identification of aberrant luminal progenitors and mTORC1 as a potential breast cancer prevention target in BRCA2 mutation carriers
    Rachel Joyce, Rosa Pascual, Luuk S. Heitink, Bianca D. Capaldo, François Vaillant, Michael Christie, Minhsuang Tsai, Elliot E. Surgenor, Casey J. A. Anttila, Pradeep Rajasekhar et al. · 2024 · Nature Cell Biology
  8. Humanization of the mouse mammary gland by replacement of the luminal layer with genetically-engineered preneoplastic human cells
    Stéphanie Verbeke, Élodie Richard, Elodie Monceau, Xenia Schmidt, Benoı̂t Rousseau, Valérie Velasco, David Bernard, Herve R. Bonnefoi, Gaëtan Marie MacGrogan, Richard D Iggo · 2014 · Breast Cancer Research
  9. VEGFR2 targeted antibody fused with MICA stimulates NKG2D mediated immunosurveillance and exhibits potent anti-tumor activity against breast cancer
    Wei Xie, Fang Liu, Youfu Wang, Xueyan Ren, Tong Wang, Zhiguo Chen, Mingying Tang, Fumou Sun, Zhaoting Li, Min Wang et al. · 2016 · Oncotarget
  10. BRCA1 controls the cell division axis and governs ploidy and phenotype in human mammary cells
    Zhengcheng He, Nagarajan Kannan, Oksana Nemirovsky, Helen Chen, Marisa Connell, Brian Taylor, Jihong Jiang, Linda M. Pilarski, Markus C. Fleisch, Dieter Niederacher et al. · 2017 · Oncotarget
  11. An Effect of Culture Media on Epithelial Differentiation Markers in Breast Cancer Cell Lines MCF7, MDA-MB-436 and SkBr3
    Valdis Pirsko, Inese Čakstiņa, Marta Priedite, Rasma Dortane, Linda Feldmane, Miki Nakazawa, Zanda Daneberga, Jānis Gardovskis, Edvīns Miklaševičs · 2018 · Medicina
  12. Dual TGFβ/BMP Pathway Inhibition Enables Expansion and Characterization of Multiple Epithelial Cell Types of the Normal and Cancerous Breast
    Mayuri Sinha Prasad, Brijesh Kumar, Poornima Bhat‐Nakshatri, Manjushree Anjanappa, George Earl Sandusky, Kathy D. Miller, Anna Maria Storniolo, Harikrishna Nakshatri · 2019 · Molecular Cancer Research
  13. Breast-Specific Molecular Clocks Comprised of ELF5 Expression and Promoter Methylation Identify Individuals Susceptible to Cancer Initiation
    Masaru Miyano, Rosalyn W. Sayaman, Sundus Shalabi, Parijat Senapati, Jennifer C. Lopez, Brittany Lynn Angarola, Stefan Hinz, Arrianna Zirbes, Olga Anczuków, Lisa D. Yee et al. · 2021 · Cancer Prevention Research
  14. Stem cell therapy: A paradigm shift in breast cancer treatment
    Sabiha M. Khan, Moushumi Suryavanshi, Jasamrit Kaur, Debadatta Nayak, Anil Kumar Khurana, Raj Kumar Manchanda, Chanderdeep Tandon, Simran Tandon · 2021 · World Journal of Stem Cells
  15. Lympho-vascular invasion in BRCA related breast cancer compared to sporadic controls
    Marise R. Heerma van Voss, Petra van der Groep, Joost Bart, Elsken van der Wall, P. J. van Diest · 2010 · BMC Cancer
  16. Biomarkers for Breast Cancer Stem Cells: The Challenges Ahead
    Yesim Gökmen‐Polar, Harikrishna Nakshatri, Sunil Badve · 2011 · Biomarkers in Medicine
  17. Cell fate takes a slug in BRCA1-associated breast cancer
    Geoffrey John Lindeman, Jane E. Visvader · 2011 · Breast Cancer Research
  18. Breast Cancer Intra-Tumor Heterogeneity: One Tumor, Different Entities
    José Esparza‐López, Elizabeth Escobar-Arriaga, Santos Soto-Germes, Marı́a de Jesús Ibarra-Sánchez · 2017 · Revista de investigaci�n Cl�nica
  19. Stem cell technology in breast cancer: current status and potential applications
    Rena Chiotaki, Hara Polioudaki, Panayiotis A. Theodoropoulos · 2016 · Stem Cells and Cloning Advances and Applications
  20. Tissue-Specific Carcinogens as Soil to Seed BRCA1/2-Mutant Hereditary Cancers
    Anup Kumar Singh, Xiaochun Yu · 2020 · Trends in cancer
  21. The current staging and classification systems of breast cancer and their pitfalls: Is it possible to integrate the complexity of this neoplasm into a unified staging system?
    Felipe Andrés Cordero da Luz, Breno Jeha Araújo, Rogério Agenor de Araújo · 2022 · Critical Reviews in Oncology/Hematology
  22. BRCA1 deficiency in mature CD8+ T lymphocytes impairs antitumor immunity
    Bogang Wu, Leilei Qi, Huai-Chin Chiang, Haihui Pan, Xiaowen Zhang, Alexandra Greenbaum, Elizabeth Stark, Li‐Ju Wang, Yidong Chen, Bassem R. Haddad et al. · 2023 · Journal for ImmunoTherapy of Cancer
  23. Hypoxia induced responses are reflected in the stromal proteome of breast cancer
    Silje Kjølle, Kenneth Finne, Even Birkeland, Vandana V. Ardawatia, Ingeborg Winge, Sura M. Aziz, Gøril Knutsvik, Elisabeth Wik, João A. Paulo, Heidrun Vethe et al. · 2023 · Nature Communications
  24. Brca1 haploinsufficiency promotes early tumor onset and epigenetic alterations in a mouse model of hereditary breast cancer
    Carman Man-Chung Li, Anna F. Cordes, Michael U. J. Oliphant, S. Aidan Quinn, Mayura Thomas, Laura M. Selfors, Francesca Silvestri, Nomeda Girnius, Gianmarco Rinaldi, Jason J. Zoeller et al. · 2024 · Nature Genetics
  25. Retinoblastoma tumor suppressor functions shared by stem cell and cancer cell strategies
    Susumu Kohno, Shunsuke Kitajima, Nobunari Sasaki, Chiaki Takahashi · 2016 · World Journal of Stem Cells
  26. Estrogen induces c-Kit and an aggressive phenotype in a model of invasive lobular breast cancer
    Joshua Chuck Harrell, Thomas M. Shroka, Britta M. Jacobsen · 2017 · Oncogenesis
  27. Genome-wide multi-omics profiling of the 8p11-p12 amplicon in breast carcinoma
    Toshima Z. Parris, Elisabeth Werner Rönnerman, Hanna Engqvist, Jana Biermann, Katarina Truvé, Szilárd Nemes, Eva B. Forssell-Aronsson, Giovanni Solinas, Anikó Kovács, Per Karlsson et al. · 2018 · Oncotarget
  28. Integrating single-cell RNA-sequencing and functional assays to decipher mammary cell states and lineage hierarchies
    Joseph L. Regan, Matthew John Smalley · 2020 · npj Breast Cancer
  29. In vivo genome‐editing screen identifies tumor suppressor genes that cooperate with Trp53 loss during mammary tumorigenesis
    Luuk S. Heitink, James Richard Whittle, François Vaillant, Bianca D. Capaldo, Johanna F. Dekkers, Caleb A. Dawson, Michael J. G. Milevskiy, Elliot E. Surgenor, Minhsuang Tsai, Huei‐Rong Chen et al. · 2022 · Molecular Oncology
  30. Molecular Classification of Breast Cancer
    Robin L. Jones, Anastasia Constantinidou, Jorge Sergio Reis-Filho · 2012 · Surgical pathology clinics
  31. ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer
    Batoul Kaabi, Ghania Belaaloui, Wassila Benbrahim, Kamel Hamizi, Mourad Sadelaoud, Wided Toumi, Hocine Bounecer · 2015 · Pathology & Oncology Research
  32. New insights from the widening homogeneity perspective to target intratumor heterogeneity
    Mengying Tong, Ziqian Deng, Xiaolong Zhang, Bin He, Meng‐Ying Yang, Wei Cheng, Quentin Liu · 2018 · 癌症：英文版
  33. Canonical PRC2 function is essential for mammary gland development and affects chromatin compaction in mammary organoids
    Ewa Malgorzata Michalak, Michael J. G. Milevskiy, Rachel Joyce, Johanna F. Dekkers, Paul R. Jamieson, Bhupinder Pal, Caleb A. Dawson, Yifang Hu, Stuart H. Orkin, Warren S. Alexander et al. · 2018 · PLoS Biology
  34. Plasticity and Potency of Mammary Stem Cell Subsets During Mammary Gland Development
    Eun-Mi Lee, Raziye Piranlioglu, Max S. Wicha, Hasan Körkaya · 2019 · International Journal of Molecular Sciences
  35. CXCR4+ mammary gland macrophageal niche promotes tumor initiating cell activity and immune suppression during tumorigenesis
    Eun-Mi Lee, Jason J Hong, Gabriel Samcam Vargas, Natalie Sauerwald, Yong Wei, Xiang Hang, Chandra L. Theesfeld, Jean Arly Volmar, Jennifer M. Miller, Wei Wang et al. · 2025 · Nature Communications
  36. New HER2-negative breast cancer subtype responsive to anti-HER2 therapy identified
    Ian A. MacNeil, David J. Burns, Benjamin E. Rich, Sajjad M. Soltani, SM Kharbush, Nicole G. Osterhaus, Brian F. Sullivan, Douglas M. Hawkins, Jodie R. Pietruska, Lance G. Laing · 2020 · Journal of Cancer Research and Clinical Oncology
  37. The Emerging Roles of π Subunit-Containing GABAA Receptors in Different Cancers
    Iman Imtiyaz Ahmed Juvale, Zurina Hassan, Ahmad Tarmizi Che Has · 2021 · International Journal of Medical Sciences
  38. Integrating spatial transcriptomics and single-cell RNA-sequencing reveals the alterations in epithelial cells during nodular formation in benign prostatic hyperplasia
    Xiawei Fei, Jican Liu, Junyan Xu, Hongyan Jing, Zhonglin Cai, Jiasheng Yan, Zhenqi Wu, Huifeng Li, Zhong Wang, Yanting Shen · 2024 · Journal of Translational Medicine
  39. Development of a test that measures real-time HER2 signaling function in live breast cancer cell lines and primary cells
    Yao Huang, David J. Burns, Benjamin E. Rich, Ian A. MacNeil, Abhijit Dandapat, Sajjad M. Soltani, Samantha Myhre, Brian F. Sullivan, Carol Ann Lange, Leo T. Furcht et al. · 2017 · BMC Cancer
  40. BCL11B Drives Human Mammary Stem Cell Self-Renewal In Vitro by Inhibiting Basal Differentiation
    Daniel H. Miller, Dexter X. Jin, Ethan S. Sokol, Janel R. Cabrera, Daphne A. Superville, Rebecca A. Gorelov, Charlotte Kuperwasser, Piyush B. Gupta · 2018 · Stem Cell Reports
  41. IGF1R constitutive activation expands luminal progenitors and influences lineage differentiation during breast tumorigenesis
    Susan M. Farabaugh, Beate C. Litzenburger, Ashuvinee Elangovan, Geoffrey L. Pecar, Lauren Walheim, Jennifer M. Atkinson, Adrian V. Lee · 2020 · Developmental Biology
  42. Functional Gene Expression Differentiation of the Notch Signaling Pathway in Female Reproductive Tract Tissues—A Comprehensive Review With Analysis
    Magdalena Orzechowska, Dorota Anusewicz, Andrzej Kazimierz Bednarek · 2020 · Frontiers in Cell and Developmental Biology
  43. High-throughput surface marker screen on primary human breast tissues reveals further cellular heterogeneity
    Siru Virtanen, Reiner Schulte, Julia Stingl, Carlos Caldas, Mona Shehata · 2021 · Breast Cancer Research
  44. The histone methyltransferase EZH2 promotes mammary stem and luminal progenitor cell expansion, metastasis and inhibits estrogen receptor-positive cellular differentiation in a model of basal breast cancer
    Jianchun Wu, David L. Crowe · 2015 · Oncology Reports
  45. Implications of Different CA 15-3 Levels according to Breast Cancer Subtype at Initial Diagnosis of Recurrent or Metastatic Breast Cancer
    Silvia Park, Hee Kyung Ahn, Lee Chun Park, Deok Won Hwang, Jun Ho Ji, Chi Hoon Maeng, Su-Hee Cho, Ji Yean Lee, Kyung Tae Park, Jin Seok Ahn et al. · 2012 · Oncology
  46. Genome-wide search identifies Ccnd2 as a direct transcriptional target of Elf5 in mouse mammary gland
    Rosalba Escamilla-Hernández, Rumela Chakrabarti, R. Romano, K. Smalley, Qian-Qian Zhu, William K. M. Lai, M. Halfon, Michael J. Buck, S. Sinha · 2010 · BMC Molecular Biology
  47. Importance of Breast Cancer Subtype in the Development of Androgen-Receptor-Directed Therapy
    Elgene Lim, Min Ni, Shiliang A. Cao, Aditi Hazra, Rulla M. Tamimi, Myles A Brown · 2014 · Current Breast Cancer Reports
  48. Coalescing single-cell genomes and transcriptomes to decode breast cancer progression
    Kaile Wang, Rui Ye, Shanshan Bai, Zhenna Xiao, Lei Yang, Jianzhuo Li, Chenling Tang, Emi Sei, Jinyu Peng, Tod D. Casasent et al. · 2025 · Cell
  49. Cytokeratins 5 and 17 Maintain an Aggressive Epithelial State in Basal-Like Breast Cancer
    Olivia McGinn, Duncan Riley, Jessica Finlay-Schultz, Kiran Vinod-Paul, Peter Kabos, Carol A. Sartorius · 2022 · Molecular Cancer Research
  50. Cellular Plasticity in Mammary Gland Development and Breast Cancer
    Madison N. Wicker, Kay‐Uwe Wagner · 2023 · Cancers
  51. Oncogenic transcription factors instruct promoter-enhancer hubs in individual triple negative breast cancer cells
    Jing-Ru Zhao, Yeqiao Zhou, Ilias Tzelepis, Noah Burget, Jun-Wei Shi, R. Faryabi · 2024 · Science Advances
  52. Defining the regulatory logic of breast cancer using single-cell epigenetic and transcriptome profiling
    Matthew J. Regner, Susana García‐Recio, Aatish Thennavan, Kamila Wiśniewska, Raúl Méndez-Giráldez, Brooke Felsheim, Philip M. Spanheimer, Joel S. Parker, Charles M. Perou, Hector L. Franco · 2025 · Cell Genomics
  53. ERrrr…Where are the Progenitors? Hormone Receptors and Mammary Cell Heterogeneity
    Giusy Tornillo, Matthew John Smalley · 2015 · Journal of Mammary Gland Biology and Neoplasia
  54. BRACking news on triple-negative/basal-like breast cancers: how BRCA1 deficiency may result in the development of a selective tumor subtype
    Manuela Santarosa, Roberta Maestro · 2011 · Cancer and Metastasis Reviews
  55. p130Cas alters the differentiation potential of mammary luminal progenitors by deregulating c-Kit activity
    Giusy Tornillo, Angela Rita Elia, Isabella Castellano, Michela Spadaro, Paola Bernabei, Brigitte Bisarò, Maria del Pilar Camacho Leal, Alessandra Pincini, Paolo Provero, Anna Sapino et al. · 2013 · Stem Cells
  56. Proliferation and ovarian hormone signaling are impaired in normal breast tissues from women with BRCA1 mutations: benefit of a progesterone receptor modulator treatment as a breast cancer preventive strategy in women with inherited BRCA1 mutations
    Laudine Communal, Myriam Vilasco, Justine Hugon‐Rodin, Aurélie Courtin, Najat Mourra, Najiba Lahlou, Morwenna Le Guillou, Muriel Perrault de Jotemps, Marie‐Pierre Chauvet, Marc Chaouat et al. · 2016 · Oncotarget
  57. Mammary stem cells: angels or demons in mammary gland?
    Xueman Chen, Qiang Liu, Erwei Song · 2017 · Signal Transduction and Targeted Therapy
  58. Annexin A8 Identifies a Subpopulation of Transiently Quiescent c-Kit Positive Luminal Progenitor Cells of the Ductal Mammary Epithelium
    Juan Manuel Iglesias, Claire J. Cairney, Roderick K. Ferrier, Laura McDonald, Kelly Soady, Howard D. Kendrick, Marie Anne Pringle, Reginald Owen Morgan, Finian Martin, Matthew John Smalley et al. · 2015 · PLoS ONE
  59. Triple-Negative Breast Cancer
    Quyen D. Chu, Tari A. King, Thelma C. Hurd · 2012 · International Journal of Breast Cancer
  60. Breast Cancer Prevention for BRCA1 and BRCA2 Mutation Carriers: Is There a role for Tamoxifen?
    Kelly‐Anne Phillips, Geoffrey John Lindeman · 2014 · Future Oncology
  61. The pathobiology of mammographic density
    Kara L. Britt, Wendy V. Ingman, Cecilia W. Huo, Grace L. Chew, Erik W. Thompson · 2014 · QUT ePrints (Queensland University of Technology)
  62. Individualized Breast Cancer Characterization through Single-Cell Analysis of Tumor and Adjacent Normal Cells
    Manjushree Anjanappa, Angelo A. Cardoso, Lijun Cheng, Safa Mohamad, Andrea Michelle Gunawan, Susan E. Rice, Yan Dong, Lang Li, George Earl Sandusky, Edward F. Srour et al. · 2017 · Cancer Research
  63. Antitumor agents 279. Structure–activity relationship and in vivo studies of novel 2-(furan-2-yl)naphthalen-1-ol (FNO) analogs as potent and selective anti-breast cancer agents
    Yizhou Dong, Kyoko Nakagawa‐Goto, Chin-Yu Lai, Yoon Kim, Susan Lynne Morris-Natschke, Eva Y-H. P. Lee, Kenneth F. Bastow, Kuo‐Hsiung Lee · 2010 · Bioorganic & Medicinal Chemistry Letters
  64. Inverse agonists of retinoic acid receptor/retinoid X receptor signaling as lineage-specific antitumor agents against human adenoid cystic carcinoma
    Sara Viragova, Luis Aparicio, Pierangela Palmerini, Junfei Zhao, Luis E. Valencia Salazar, Alexandra Schurer, Anika Dhuri, Debashis Sahoo, Christopher A. Moskaluk, Raúl Rabadán et al. · 2023 · JNCI Journal of the National Cancer Institute
  65. Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer
    Isabel Tundidor, Marta Seijo-Vila, Sandra Blasco-Benito, María Rubert-Hernández, Sandra Adámez-Rodríguez, Clara Andradas, Sara Manzano, Isabel Álvarez, Cristina Sarasqueta, María Villa‐Morales et al. · 2023 · Nature Communications
  66. Epigenomic disorder and partial EMT impair luminal progenitor integrity in Brca1-associated breast tumorigenesis
    Camille Landragin, Mélissa Saichi, Marthe Laisné, Adeline Durand, Pacôme Prompsy, Renaud Leclère, Jérémy Mesple, Kyra J. E. Borgman, Amandine Trouchet, Marisa M. Faraldo et al. · 2025 · Molecular Cancer
  67. PTEN is required to maintain luminal epithelial homeostasis and integrity in the adult mammary gland
    Shore, Amy N., Chang, Chi-Hsuan, Kwon, Oh-Joon, Weston, Matthew C., Zhang, Mei, Xin, Li, Rosen, Jeffrey M. · 2016 · Developmental Biology
  68. Induced Expression of Cancer Stem Cell Markers ALDH1A3 and Sox-2 in Hierarchical Reconstitution of Apoptosis-resistant Human Breast Cancer Cells
    Karin Kashii-Magaribuchi, Rie Takeuchi, Yuko Haisa, Akemi Sakamoto, Aimi Itoh, Yuki Izawa, Miyuki Isa, Mayu Fukuzawa, Motonobu Murakami, Rei Takahashi · 2016 · ACTA HISTOCHEMICA ET CYTOCHEMICA
  69. Age at first full-term birth and breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Joanne Kotsopoulos, Jacek Gronwald, Henry T. Lynch, Andrea F. Eisen, Susan L. Neuhausen, Nadine Tung, Peter Ainsworth, Jeffrey N. Weitzel, Tuya Pal, William David Foulkes et al. · 2018 · Breast Cancer Research and Treatment
  70. Patterns of Tumor Progression Predict Small and Tissue-Specific Tumor-Originating Niches
    Thomas Buder, Andreas Deutsch, Barbara Klink, Anja Voß-Böhme · 2019 · Frontiers in Oncology
  71. In vivo imaging of mammary epithelial cell dynamics in response to lineage-biased Wnt/β-catenin activation
    Bethan Lloyd‐Lewis, Francesca Gobbo, Meghan Perkins, Guillaume Jacquemin, Mathilde Huyghe, Marisa M. Faraldo, Silvia Fré · 2022 · Cell Reports
  72. Breast pathology: beyond morphology
    Peter T. Simpson, Jorge Sergio Reis-Filho, Sunil R. Lakhani · 2010 · Seminars in Diagnostic Pathology
  73. Mammary gland stem cells: More puzzles than explanations
    Suneesh Kaimala, Swathi Bisana, Satish Kumar · 2012 · Journal of Biosciences
  74. A Core Invasiveness Gene Signature Reflects Epithelial-to-Mesenchymal Transition but Not Metastatic Potential in Breast Cancer Cell Lines and Tissue Samples
    Melike Marsan, Gert Van den Eynden, Ridha Limame, Patrick Neven, Jan Hauspy, Peter A. van Dam, Ignace B. Vergote, Luc Yves Dirix, Peter B. Vermeulen, Steven Van Laere · 2014 · PLoS ONE
  75. A High-Content Assay to Identify Small-Molecule Modulators of a Cancer Stem Cell Population in Luminal Breast Cancer
    Byong Hoon Yoo, Sunshine Daddario Axlund, Peter Kabos, Brian G. Reid, Jerome B. Schaack, Carol A. Sartorius, Daniel V. LaBarbera · 2012 · SLAS DISCOVERY
  76. Pathobiology of the 129:Stat1 −/− mouse model of human age-related ER-positive breast cancer with an immune infiltrate-excluded phenotype
    Hidetoshi Mori, Jane Q. Chen, Robert D. Cardiff, Zsófia Pénzváltó, Neil E. Hubbard, Louis Schuetter, Russell C. Hovey, Josephine F. Trott, Alexander D. Borowsky · 2017 · Breast Cancer Research
  77. RainBio: Proportional Visualization of Large Sets in Biology
    Jean-Baptiste Lamy, Rosy Tsopra · 2019 · IEEE Transactions on Visualization and Computer Graphics
  78. In Vitro Methods to Culture Primary Human Breast Epithelial Cells
    Afshin Raouf, Yu Jia Sun · 2012 · Methods in molecular biology
  79. Function Follows Form: Defining Mammary Stem Cells
    María dM Vivanco · 2010 · Science Translational Medicine
  80. Células madre tumorales: una diana terapéutica en el cáncer de mama
    Arrate Eguiara, Kepa Elorriaga, Ricardo Rezola, Ángel G. Martín · 2012 · Revista de Senología y Patología Mamaria
  81. Intercellular hif1α reprograms mammary progenitors and myeloid immune evasion to drive high-risk breast lesions
    Irene Bertolini, Michela Perego, Yulia Nefedova, Cindy Lin, Andrew T. Milcarek, Peter Vogel, Jagadish C. Ghosh, Andrew V. Kossenkov, Dario C. Altieri · 2023 · Journal of Clinical Investigation
  82. Single cell profiling of female breast fibroadenoma reveals distinct epithelial cell compositions and therapeutic targets
    Zhigang Chen, Yi Zhang, Wenlu Li, Chenyi Gao, Fengbo Huang, Lu Cheng, Menglei Jin, Xiaoming Xu, Jian Huang · 2023 · Nature Communications
  83. High SPDEF may identify patients who will have a prolonged response to androgen deprivation therapy
    Andrew Haller, Wei Tan, Rochelle Payne Ondracek, Willie Underwood, Lili Tian, Carl Morrison, Fengzhi Li · 2013 · The Prostate
  84. A Phenotypic Mouse Model of Basaloid Breast Tumors
    Soyoung Kim, Avtar Roopra, Caroline M. Alexander · 2012 · PLoS ONE
  85. Pathologic Features and Immunophenotype of Estrogen Receptor–positive Breast Cancers in BRCA1 Mutation Carriers
    Jennifer S. Kaplan, Stuart J. Schnitt, Laura C. Collins, Yihong Wang, Judy Ellen Garber, Kelli D. Montgomery, Robert B. West, Karen J. Krag, Katharina Fetten, Anne Lincoln et al. · 2012 · The American Journal of Surgical Pathology
  86. Lack of ABCG2 Shortens Latency of BRCA1-Deficient Mammary Tumors and This Is Not Affected by Genistein or Resveratrol
    Serge A.L. Zander, Ariena J. Kersbergen, Wendy Sol, Maaike A Gonggrijp, Koen van de Wetering, Jos Jonkers, Piet Borst, Sven Rottenberg · 2012 · Cancer Prevention Research
  87. Stem Cell Maintenance of the Mammary Gland: It Takes Two
    Patricia J. Keller, Lisa M. Arendt, Charlotte Kuperwasser · 2011 · Cell stem cell
  88. Biomarkers to Target Heterogeneous Breast Cancer Stem Cells
    Wendy W. Hwang‐Verslues · 2012 · Journal of Molecular Biomarkers & Diagnosis
  89. FOXC1 Is Enriched in the Mammary Luminal Progenitor Population, but Is Not Necessary for Mouse Mammary Ductal Morphogenesis1
    Gina M. Sizemore, Steven T. Sizemore, Bhupinder Pal, Christine Noga Booth, Darcie D. Seachrist, Fadi W. Abdul‐Karim, Tsutomu Kume, Ruth A. Keri · 2013 · Biology of Reproduction
  90. Gene-expression patterns in peripheral blood classify familial breast cancer susceptibility
    Stephen Piccolo, Irene Louise Andrulis, Adam Louis Cohen, Thomas A. Conner, Philip J. Moos, Avrum E. Spira, Saundra S. Buys, William Evan Johnson, Andrea H. Bild · 2015 · BMC Medical Genomics
  91. Spatially correlated phenotyping reveals K5-positive luminal progenitor cells and p63-K5/14-positive stem cell-like cells in human breast epithelium
    Werner Boecker, Laura van Horn, Göran Stenman, Christine Stürken, Udo Schumacher, Thomas Loening, Lukas F. Liesenfeld, Eberhard Korsching, Doreen Gläser, Katharina Tiemann et al. · 2018 · Laboratory Investigation
  92. Expression of the stem cell marker ALDH1 in the normal breast of BRCA1 mutation carriers
    Marise R. Heerma van Voss, Petra van der Groep, Joost Bart, Elsken van der Wall, P. J. van Diest · 2010 · Breast Cancer Research and Treatment
  93. Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic?
    Sunil R. Lakhani, Kum Kum Khanna, Georgia Chenevix‐Trench · 2010 · Breast Cancer Research
  94. Testing conditional independence in supervised learning algorithms
    Watson, David S., Wright, Marvin N. · 2021 · Machine Learning
  95. Advances in prognostic and predictive biomarkers for breast cancer: Integrating multigene assays, hormone receptors, and emerging circulating biomarkers
    Sagar Mondal, Subham Preetam, Ravi Kumar Deshwal, Shailendra Thapliyal, Sarvesh Rustagi, Saad Ali Alghamdi, Nayan Talukdar, Richa Mishra, Jutishna Bora, Soham Banerjee et al. · 2025 · Clinica Chimica Acta
  96. Distinct niche structures and intrinsic programs of fallopian tube and ovarian surface epithelial cells
    Guyu Tracy Qin, Eunsil Park, Xueqing Chen, Sen Han, Dongxi Xiang, Fang Ren, Gang Liu, Huidong Chen, Guo‐Cheng Yuan, Zhe Li · 2022 · iScience
  97. Cytokeratin 5–Positive Cells Represent a Therapy Resistant subpopulation in Epithelial Ovarian Cancer
    Bradley R. Corr, Jessica Finlay-Schultz, Rachel B. Rosen, Lubna Qamar, Miriam D. Post, Kian Behbakht, Monique A. Spillman, Carol A. Sartorius · 2015 · International Journal of Gynecological Cancer
  98. Circulating estrogens and estrogens within the breast among postmenopausal BRCA1/2 mutation carriers
    Jennifer T. Loud, Gretchen L. Gierach, Timothy D. Veenstra, Roni T. Falk, Kathryn Nichols, Allison Guttmann, Xia Xu, Mark H. Greene, Mitchell H. Gail · 2014 · Breast Cancer Research and Treatment
  99. Integrative analyses reveal signaling pathways underlying familial breast cancer susceptibility
    Stephen Piccolo, Laura M. Hoffman, Thomas A. Conner, Gajendra Shrestha, Adam Louis Cohen, Jeffrey R. Marks, Leigh A. Neumayer, Cori Agarwal, Mary C. Beckerle, Irene Louise Andrulis et al. · 2016 · Molecular Systems Biology
  100. Activation of CD44 signaling in leader cells induced by tumor-associated macrophages drives collective detachment in luminal breast carcinomas
    Feng Gao, Guoliang Zhang, Yiwen Liu, Yiqing He, Yumeng Sheng, Xiaodan Sun, Yan Du, Cuixia Yang · 2022 · Cell Death and Disease